ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable Ketamine Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-3N18859
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Injectable Ketamine Market Research Report 2024
BUY CHAPTERS

Global Injectable Ketamine Market Research Report 2024

Code: QYRE-Auto-3N18859
Report
November 2024
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Bnm Organics
Seqens
Neon Laboratories
Samarth Pharma
Sun Pharmaceuticals
Supriya Lifesciences
Taj Pharmaceuticals
Hengrui
Anhui Wanhe Pharmaceutical
Greenco Biologicals
Troikaa Parenterals
Ketalar
Hameln Pharma ltd

Injectable Ketamine Market Size

The global market for Injectable Ketamine was valued at US$ 658 million in the year 2023 and is projected to reach a revised size of US$ 1865 million by 2030, growing at a CAGR of 16.4% during the forecast period.

Injectable Ketamine Market

Injectable Ketamine Market

Injectable ketamine is a form of the anesthetic drug ketamine that is administered via injection, typically intravenously (IV) or intramuscularly (IM). Ketamine is a dissociative anesthetic, meaning it causes a sense of detachment from the body and environment. It was originally developed in the 1960s as an anesthetic for surgical procedures but has since found various uses in both medical and psychiatric settings.
North American market for Injectable Ketamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injectable Ketamine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Injectable Ketamine include Greenco Biologicals, Pfizer, BNM Organics, Seqens, Troikaa Parenterals, Neon Laboratories, Samarth Pharma, Sun Pharmaceuticals, Supriya Lifesciences, Taj Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable Ketamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Ketamine.
The Injectable Ketamine market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Injectable Ketamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Ketamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Injectable Ketamine Market Report

Report Metric Details
Report Name Injectable Ketamine Market
Accounted market size in year US$ 658 million
Forecasted market size in 2030 US$ 1865 million
CAGR 16.4%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Greenco Biologicals, Pfizer, BNM Organics, Seqens, Troikaa Parenterals, Neon Laboratories, Samarth Pharma, Sun Pharmaceuticals, Supriya Lifesciences, Taj Pharmaceuticals, Hengrui, Anhui Wanhe Pharmaceutical, Ketalar, Hameln Pharma ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Injectable Ketamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Injectable Ketamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Injectable Ketamine Market growing?

Ans: The Injectable Ketamine Market witnessing a CAGR of 16.4% during the forecast period 2024-2030.

What is the Injectable Ketamine Market size in 2030?

Ans: The Injectable Ketamine Market size in 2030 will be US$ 1865 million.

Who are the main players in the Injectable Ketamine Market report?

Ans: The main players in the Injectable Ketamine Market are Greenco Biologicals, Pfizer, BNM Organics, Seqens, Troikaa Parenterals, Neon Laboratories, Samarth Pharma, Sun Pharmaceuticals, Supriya Lifesciences, Taj Pharmaceuticals, Hengrui, Anhui Wanhe Pharmaceutical, Ketalar, Hameln Pharma ltd

What are the Application segmentation covered in the Injectable Ketamine Market report?

Ans: The Applications covered in the Injectable Ketamine Market report are Anesthetic Use, Pain Management, Mental Health Treatment

What are the Type segmentation covered in the Injectable Ketamine Market report?

Ans: The Types covered in the Injectable Ketamine Market report are Low-Dose Ketamine, Standard Ketamine, High-Dose Ketamine

Recommended Reports

Injectable Solutions

Anesthesia Markets

Pain Management

1 Injectable Ketamine Market Overview
1.1 Product Definition
1.2 Injectable Ketamine by Type
1.2.1 Global Injectable Ketamine Market Value Comparison by Type (2024-2030)
1.2.2 Low-Dose Ketamine
1.2.3 Standard Ketamine
1.2.4 High-Dose Ketamine
1.3 Injectable Ketamine by Application
1.3.1 Global Injectable Ketamine Market Value by Application (2024-2030)
1.3.2 Anesthetic Use
1.3.3 Pain Management
1.3.4 Mental Health Treatment
1.4 Global Injectable Ketamine Market Size Estimates and Forecasts
1.4.1 Global Injectable Ketamine Revenue 2019-2030
1.4.2 Global Injectable Ketamine Sales 2019-2030
1.4.3 Global Injectable Ketamine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Ketamine Market Competition by Manufacturers
2.1 Global Injectable Ketamine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Ketamine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Ketamine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Injectable Ketamine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Ketamine, Product Type & Application
2.7 Global Key Manufacturers of Injectable Ketamine, Date of Enter into This Industry
2.8 Global Injectable Ketamine Market Competitive Situation and Trends
2.8.1 Global Injectable Ketamine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injectable Ketamine Players Market Share by Revenue
2.8.3 Global Injectable Ketamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Ketamine Market Scenario by Region
3.1 Global Injectable Ketamine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Ketamine Sales by Region: 2019-2030
3.2.1 Global Injectable Ketamine Sales by Region: 2019-2024
3.2.2 Global Injectable Ketamine Sales by Region: 2025-2030
3.3 Global Injectable Ketamine Revenue by Region: 2019-2030
3.3.1 Global Injectable Ketamine Revenue by Region: 2019-2024
3.3.2 Global Injectable Ketamine Revenue by Region: 2025-2030
3.4 North America Injectable Ketamine Market Facts & Figures by Country
3.4.1 North America Injectable Ketamine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Ketamine Sales by Country (2019-2030)
3.4.3 North America Injectable Ketamine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Ketamine Market Facts & Figures by Country
3.5.1 Europe Injectable Ketamine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Ketamine Sales by Country (2019-2030)
3.5.3 Europe Injectable Ketamine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Ketamine Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Ketamine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Ketamine Sales by Region (2019-2030)
3.6.3 Asia Pacific Injectable Ketamine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injectable Ketamine Market Facts & Figures by Country
3.7.1 Latin America Injectable Ketamine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Ketamine Sales by Country (2019-2030)
3.7.3 Latin America Injectable Ketamine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable Ketamine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Ketamine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Ketamine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Ketamine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Ketamine Sales by Type (2019-2030)
4.1.1 Global Injectable Ketamine Sales by Type (2019-2024)
4.1.2 Global Injectable Ketamine Sales by Type (2025-2030)
4.1.3 Global Injectable Ketamine Sales Market Share by Type (2019-2030)
4.2 Global Injectable Ketamine Revenue by Type (2019-2030)
4.2.1 Global Injectable Ketamine Revenue by Type (2019-2024)
4.2.2 Global Injectable Ketamine Revenue by Type (2025-2030)
4.2.3 Global Injectable Ketamine Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Ketamine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Ketamine Sales by Application (2019-2030)
5.1.1 Global Injectable Ketamine Sales by Application (2019-2024)
5.1.2 Global Injectable Ketamine Sales by Application (2025-2030)
5.1.3 Global Injectable Ketamine Sales Market Share by Application (2019-2030)
5.2 Global Injectable Ketamine Revenue by Application (2019-2030)
5.2.1 Global Injectable Ketamine Revenue by Application (2019-2024)
5.2.2 Global Injectable Ketamine Revenue by Application (2025-2030)
5.2.3 Global Injectable Ketamine Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Ketamine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Greenco Biologicals
6.1.1 Greenco Biologicals Company Information
6.1.2 Greenco Biologicals Description and Business Overview
6.1.3 Greenco Biologicals Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Greenco Biologicals Injectable Ketamine Product Portfolio
6.1.5 Greenco Biologicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Injectable Ketamine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 BNM Organics
6.3.1 BNM Organics Company Information
6.3.2 BNM Organics Description and Business Overview
6.3.3 BNM Organics Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BNM Organics Injectable Ketamine Product Portfolio
6.3.5 BNM Organics Recent Developments/Updates
6.4 Seqens
6.4.1 Seqens Company Information
6.4.2 Seqens Description and Business Overview
6.4.3 Seqens Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Seqens Injectable Ketamine Product Portfolio
6.4.5 Seqens Recent Developments/Updates
6.5 Troikaa Parenterals
6.5.1 Troikaa Parenterals Company Information
6.5.2 Troikaa Parenterals Description and Business Overview
6.5.3 Troikaa Parenterals Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Troikaa Parenterals Injectable Ketamine Product Portfolio
6.5.5 Troikaa Parenterals Recent Developments/Updates
6.6 Neon Laboratories
6.6.1 Neon Laboratories Company Information
6.6.2 Neon Laboratories Description and Business Overview
6.6.3 Neon Laboratories Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Neon Laboratories Injectable Ketamine Product Portfolio
6.6.5 Neon Laboratories Recent Developments/Updates
6.7 Samarth Pharma
6.7.1 Samarth Pharma Company Information
6.7.2 Samarth Pharma Description and Business Overview
6.7.3 Samarth Pharma Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Samarth Pharma Injectable Ketamine Product Portfolio
6.7.5 Samarth Pharma Recent Developments/Updates
6.8 Sun Pharmaceuticals
6.8.1 Sun Pharmaceuticals Company Information
6.8.2 Sun Pharmaceuticals Description and Business Overview
6.8.3 Sun Pharmaceuticals Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sun Pharmaceuticals Injectable Ketamine Product Portfolio
6.8.5 Sun Pharmaceuticals Recent Developments/Updates
6.9 Supriya Lifesciences
6.9.1 Supriya Lifesciences Company Information
6.9.2 Supriya Lifesciences Description and Business Overview
6.9.3 Supriya Lifesciences Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Supriya Lifesciences Injectable Ketamine Product Portfolio
6.9.5 Supriya Lifesciences Recent Developments/Updates
6.10 Taj Pharmaceuticals
6.10.1 Taj Pharmaceuticals Company Information
6.10.2 Taj Pharmaceuticals Description and Business Overview
6.10.3 Taj Pharmaceuticals Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Taj Pharmaceuticals Injectable Ketamine Product Portfolio
6.10.5 Taj Pharmaceuticals Recent Developments/Updates
6.11 Hengrui
6.11.1 Hengrui Company Information
6.11.2 Hengrui Description and Business Overview
6.11.3 Hengrui Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hengrui Injectable Ketamine Product Portfolio
6.11.5 Hengrui Recent Developments/Updates
6.12 Anhui Wanhe Pharmaceutical
6.12.1 Anhui Wanhe Pharmaceutical Company Information
6.12.2 Anhui Wanhe Pharmaceutical Description and Business Overview
6.12.3 Anhui Wanhe Pharmaceutical Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Anhui Wanhe Pharmaceutical Injectable Ketamine Product Portfolio
6.12.5 Anhui Wanhe Pharmaceutical Recent Developments/Updates
6.13 Ketalar
6.13.1 Ketalar Company Information
6.13.2 Ketalar Description and Business Overview
6.13.3 Ketalar Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ketalar Injectable Ketamine Product Portfolio
6.13.5 Ketalar Recent Developments/Updates
6.14 Hameln Pharma ltd
6.14.1 Hameln Pharma ltd Company Information
6.14.2 Hameln Pharma ltd Description and Business Overview
6.14.3 Hameln Pharma ltd Injectable Ketamine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Hameln Pharma ltd Injectable Ketamine Product Portfolio
6.14.5 Hameln Pharma ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Ketamine Industry Chain Analysis
7.2 Injectable Ketamine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Ketamine Production Mode & Process
7.4 Injectable Ketamine Sales and Marketing
7.4.1 Injectable Ketamine Sales Channels
7.4.2 Injectable Ketamine Distributors
7.5 Injectable Ketamine Customers
8 Injectable Ketamine Market Dynamics
8.1 Injectable Ketamine Industry Trends
8.2 Injectable Ketamine Market Drivers
8.3 Injectable Ketamine Market Challenges
8.4 Injectable Ketamine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Bnm Organics
Seqens
Neon Laboratories
Samarth Pharma
Sun Pharmaceuticals
Supriya Lifesciences
Taj Pharmaceuticals
Hengrui
Anhui Wanhe Pharmaceutical
Greenco Biologicals
Troikaa Parenterals
Ketalar
Hameln Pharma ltd
List of Tables
 Table 1. Global Injectable Ketamine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Injectable Ketamine Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Injectable Ketamine Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Injectable Ketamine Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Injectable Ketamine Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Injectable Ketamine Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Injectable Ketamine Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Injectable Ketamine Average Price (US$/kg) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Injectable Ketamine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Injectable Ketamine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Injectable Ketamine, Product Type & Application
 Table 12. Global Key Manufacturers of Injectable Ketamine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Injectable Ketamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Ketamine as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Injectable Ketamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Injectable Ketamine Sales by Region (2019-2024) & (kg)
 Table 18. Global Injectable Ketamine Sales Market Share by Region (2019-2024)
 Table 19. Global Injectable Ketamine Sales by Region (2025-2030) & (kg)
 Table 20. Global Injectable Ketamine Sales Market Share by Region (2025-2030)
 Table 21. Global Injectable Ketamine Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Injectable Ketamine Revenue Market Share by Region (2019-2024)
 Table 23. Global Injectable Ketamine Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Injectable Ketamine Revenue Market Share by Region (2025-2030)
 Table 25. North America Injectable Ketamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Injectable Ketamine Sales by Country (2019-2024) & (kg)
 Table 27. North America Injectable Ketamine Sales by Country (2025-2030) & (kg)
 Table 28. North America Injectable Ketamine Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Injectable Ketamine Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Injectable Ketamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Injectable Ketamine Sales by Country (2019-2024) & (kg)
 Table 32. Europe Injectable Ketamine Sales by Country (2025-2030) & (kg)
 Table 33. Europe Injectable Ketamine Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Injectable Ketamine Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Injectable Ketamine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Injectable Ketamine Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Injectable Ketamine Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Injectable Ketamine Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Injectable Ketamine Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Injectable Ketamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Injectable Ketamine Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Injectable Ketamine Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Injectable Ketamine Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Injectable Ketamine Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Injectable Ketamine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Injectable Ketamine Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Injectable Ketamine Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Injectable Ketamine Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Injectable Ketamine Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Injectable Ketamine Sales (kg) by Type (2019-2024)
 Table 51. Global Injectable Ketamine Sales (kg) by Type (2025-2030)
 Table 52. Global Injectable Ketamine Sales Market Share by Type (2019-2024)
 Table 53. Global Injectable Ketamine Sales Market Share by Type (2025-2030)
 Table 54. Global Injectable Ketamine Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Injectable Ketamine Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Injectable Ketamine Revenue Market Share by Type (2019-2024)
 Table 57. Global Injectable Ketamine Revenue Market Share by Type (2025-2030)
 Table 58. Global Injectable Ketamine Price (US$/kg) by Type (2019-2024)
 Table 59. Global Injectable Ketamine Price (US$/kg) by Type (2025-2030)
 Table 60. Global Injectable Ketamine Sales (kg) by Application (2019-2024)
 Table 61. Global Injectable Ketamine Sales (kg) by Application (2025-2030)
 Table 62. Global Injectable Ketamine Sales Market Share by Application (2019-2024)
 Table 63. Global Injectable Ketamine Sales Market Share by Application (2025-2030)
 Table 64. Global Injectable Ketamine Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Injectable Ketamine Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Injectable Ketamine Revenue Market Share by Application (2019-2024)
 Table 67. Global Injectable Ketamine Revenue Market Share by Application (2025-2030)
 Table 68. Global Injectable Ketamine Price (US$/kg) by Application (2019-2024)
 Table 69. Global Injectable Ketamine Price (US$/kg) by Application (2025-2030)
 Table 70. Greenco Biologicals Company Information
 Table 71. Greenco Biologicals Description and Business Overview
 Table 72. Greenco Biologicals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 73. Greenco Biologicals Injectable Ketamine Product
 Table 74. Greenco Biologicals Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 78. Pfizer Injectable Ketamine Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. BNM Organics Company Information
 Table 81. BNM Organics Description and Business Overview
 Table 82. BNM Organics Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 83. BNM Organics Injectable Ketamine Product
 Table 84. BNM Organics Recent Developments/Updates
 Table 85. Seqens Company Information
 Table 86. Seqens Description and Business Overview
 Table 87. Seqens Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 88. Seqens Injectable Ketamine Product
 Table 89. Seqens Recent Developments/Updates
 Table 90. Troikaa Parenterals Company Information
 Table 91. Troikaa Parenterals Description and Business Overview
 Table 92. Troikaa Parenterals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 93. Troikaa Parenterals Injectable Ketamine Product
 Table 94. Troikaa Parenterals Recent Developments/Updates
 Table 95. Neon Laboratories Company Information
 Table 96. Neon Laboratories Description and Business Overview
 Table 97. Neon Laboratories Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 98. Neon Laboratories Injectable Ketamine Product
 Table 99. Neon Laboratories Recent Developments/Updates
 Table 100. Samarth Pharma Company Information
 Table 101. Samarth Pharma Description and Business Overview
 Table 102. Samarth Pharma Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 103. Samarth Pharma Injectable Ketamine Product
 Table 104. Samarth Pharma Recent Developments/Updates
 Table 105. Sun Pharmaceuticals Company Information
 Table 106. Sun Pharmaceuticals Description and Business Overview
 Table 107. Sun Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 108. Sun Pharmaceuticals Injectable Ketamine Product
 Table 109. Sun Pharmaceuticals Recent Developments/Updates
 Table 110. Supriya Lifesciences Company Information
 Table 111. Supriya Lifesciences Description and Business Overview
 Table 112. Supriya Lifesciences Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Supriya Lifesciences Injectable Ketamine Product
 Table 114. Supriya Lifesciences Recent Developments/Updates
 Table 115. Taj Pharmaceuticals Company Information
 Table 116. Taj Pharmaceuticals Description and Business Overview
 Table 117. Taj Pharmaceuticals Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. Taj Pharmaceuticals Injectable Ketamine Product
 Table 119. Taj Pharmaceuticals Recent Developments/Updates
 Table 120. Hengrui Company Information
 Table 121. Hengrui Description and Business Overview
 Table 122. Hengrui Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. Hengrui Injectable Ketamine Product
 Table 124. Hengrui Recent Developments/Updates
 Table 125. Anhui Wanhe Pharmaceutical Company Information
 Table 126. Anhui Wanhe Pharmaceutical Description and Business Overview
 Table 127. Anhui Wanhe Pharmaceutical Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. Anhui Wanhe Pharmaceutical Injectable Ketamine Product
 Table 129. Anhui Wanhe Pharmaceutical Recent Developments/Updates
 Table 130. Ketalar Company Information
 Table 131. Ketalar Description and Business Overview
 Table 132. Ketalar Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 133. Ketalar Injectable Ketamine Product
 Table 134. Ketalar Recent Developments/Updates
 Table 135. Hameln Pharma ltd Company Information
 Table 136. Hameln Pharma ltd Description and Business Overview
 Table 137. Hameln Pharma ltd Injectable Ketamine Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 138. Hameln Pharma ltd Injectable Ketamine Product
 Table 139. Hameln Pharma ltd Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Injectable Ketamine Distributors List
 Table 143. Injectable Ketamine Customers List
 Table 144. Injectable Ketamine Market Trends
 Table 145. Injectable Ketamine Market Drivers
 Table 146. Injectable Ketamine Market Challenges
 Table 147. Injectable Ketamine Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Injectable Ketamine
 Figure 2. Global Injectable Ketamine Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Injectable Ketamine Market Share by Type: 2023 & 2030
 Figure 4. Low-Dose Ketamine Product Picture
 Figure 5. Standard Ketamine Product Picture
 Figure 6. High-Dose Ketamine Product Picture
 Figure 7. Global Injectable Ketamine Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Injectable Ketamine Market Share by Application: 2023 & 2030
 Figure 9. Anesthetic Use
 Figure 10. Pain Management
 Figure 11. Mental Health Treatment
 Figure 12. Global Injectable Ketamine Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Injectable Ketamine Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Injectable Ketamine Sales (2019-2030) & (kg)
 Figure 15. Global Injectable Ketamine Average Price (US$/kg) & (2019-2030)
 Figure 16. Injectable Ketamine Report Years Considered
 Figure 17. Injectable Ketamine Sales Share by Manufacturers in 2023
 Figure 18. Global Injectable Ketamine Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Injectable Ketamine Players: Market Share by Revenue in Injectable Ketamine in 2023
 Figure 20. Injectable Ketamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Injectable Ketamine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Injectable Ketamine Sales Market Share by Country (2019-2030)
 Figure 23. North America Injectable Ketamine Revenue Market Share by Country (2019-2030)
 Figure 24. United States Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Injectable Ketamine Sales Market Share by Country (2019-2030)
 Figure 27. Europe Injectable Ketamine Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Injectable Ketamine Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Injectable Ketamine Revenue Market Share by Region (2019-2030)
 Figure 35. China Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Injectable Ketamine Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Injectable Ketamine Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Injectable Ketamine Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Injectable Ketamine Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Injectable Ketamine by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Injectable Ketamine by Type (2019-2030)
 Figure 54. Global Injectable Ketamine Price (US$/kg) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Injectable Ketamine by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Injectable Ketamine by Application (2019-2030)
 Figure 57. Global Injectable Ketamine Price (US$/kg) by Application (2019-2030)
 Figure 58. Injectable Ketamine Value Chain
 Figure 59. Injectable Ketamine Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Esketamine Hydrochloride Injection Market Research Report 2024
Global Intravenous Anesthetic Market Research Report 2025
Global Ketamine Hydrochloride Market Research Report 2024
Global Injection General Anesthetics Drug Market Research Report 2024
Global Injectable Drug Delivery Market Research Report 2024
Global Ketamine Treatment Market Research Report 2024
Global Intravenous Injection General Anesthesia Drugs Market Insights Forecast to 2030
Global Alternate site Infusion Therapy Market Insights Forecast to 2030
Injectable Anesthetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inhalational Anesthesia Drugs Market Research Report 2024
Global Inhalation Anesthesia Drugs Market Research Report 2024
Implantable Drug Delivery Devices Market
Global Inhalational Anesthetic Market Research Report 2024
Global Injection Anesthetics Drug Market Research Report 2024
Global Inhalational Anaesthesia Drugs Market Research Report 2024
Global Complex Injectable Market Research Report 2024
Global Implanted Infusion Pump Market Research Report 2025
Global Inhalation General Anesthesia Drugs Market Research Report 2024
Global Advanced Infusion Systems Market Research Report 2024
Global Sterile Injectable Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions